Skip to main
ALPN
ALPN logo

ALPN Earnings Dates & Reports

ALPN Most Recent Earnings

Report Date
Period EndingQ1 2024
Est. EPS-$0.41
Actual EPS-$0.28
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

ALPN Earnings per Share (EPS) History

Signup for full access
Browse free

ALPN Latest Earnings

The value each ALPN share was expected to gain vs. the value each share gained.

ALPN reported its most recent earnings on for Q1 2024, posting earnings per share (EPS) of -$0.28. This exceeded analysts' expectations of -$0.41 by 31.71%, marking a Beat.

For comparison, Alpine Immune Sciences reported EPS of -$0.28 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.

ALPN Earnings History

Earnings
Est. EPSActual EPSSurprise
Q1 2024
-$0.41-$0.28-31.71%
DeckReportListen
Q4 2023
-$0.34$0.15-144.12%
DeckReportListen
Q3 2023
-$0.33-$0.24-27.27%
DeckReportListen
Q2 2023
-$0.37-$0.27-27.03%
DeckReportListen
Q1 2023
-$0.37-$0.28-24.32%
DeckReportListen
View all

ALPN Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Alpine Immune Sciences’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

ALPN Earnings FAQs

ALPN last reported earnings on May 9, 2024 for Q1 2024, posting an EPS of -$0.28, which Beat the estimate of -$0.41 by 31.71%.

For Q1 2024, ALPN reported an EPS of -$0.28, exceeding analysts' estimate of -$0.41 by 31.71%.

For Q1 2024, ALPN Beat expectations with an actual EPS of -$0.28 vs. an estimated EPS of -$0.41.

Following the last earnings report on May 9, 2024, ALPN's stock price moved — from — to —.

The next ALPN earnings call is scheduled for May. 9, 2024, where executives will discuss financial results and outlook.

Alpine Immune Sciences (ALPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.